ACM Research heads into its third-quarter report with a striking disconnect. Last quarter the chip equipment maker raised the floor of its full-year revenue outlook, posted gross margins back above 46% and said first-half orders had more than doubled from a year earlier. Since then the stock has lost about 44% of its value while the S&P 500 was essentially flat. Either the market sees something the order book does not, or the shares have priced in a disappointment that the business has yet to deliver.

The Street is looking for non-GAAP earnings of $0.51 a share on revenue of about $309 million when results arrive before the open on November 5. That revenue figure would be up roughly 15% from a year ago, a notable slowdown from the mid-30% growth ACM delivered in each of the first two quarters. The earnings estimate is essentially flat with the prior quarter's $0.52 despite higher sales, which partly reflects a heavier tax burden after management lifted its effective rate guidance to 10% to 12%. The Earnings Whisper of $0.80 sits far above consensus, a gap large enough to suggest some investors expect margins and mix to carry results well beyond the published forecasts. For the full year, consensus of $1.14 billion sits slightly below the midpoint of management's narrowed $1.125 billion to $1.175 billion range, a cautious positioning that leaves room for upside if the second half holds together.

That caution has a source. On the last call, management acknowledged that second-half estimates might need trimming after a front-loaded first half, and it flagged lengthening component lead times, with some parts stretching from about four months to six. This quarter is the first real look at whether supply constraints are slipping shipments or merely tightening schedules. Revenue near or above $309 million, paired with reiterated annual guidance, would argue the bottlenecks are manageable. A shortfall blamed on parts, or any retreat toward the low end of the range, would validate the market's skepticism.

The product story matters just as much. Cleaning revenue, still the company's core franchise, fell 14% in the second quarter as single-wafer SPM tools shipped but had not yet converted to revenue. Management is targeting more than 20 SPM shipments by year-end, so evidence of progress toward that number, and any sign cleaning sales are stabilizing, would support the claim that 2026 is a big year for new products. Investors should also look for updates on the panel-level plating production and evaluation orders, and on whether PECVD and track platforms remain on pace for production qualification by year-end. Gross margin holding in the mid-40s would confirm the recovery from last year's 41% trough was structural rather than mix-driven luck. Continued diversification also deserves attention after a single customer accounted for just under 13% of first-half sales, down sharply from three large customers totaling half of revenue a year earlier.

Sentiment has soured, swinging from a neutral reading ahead of last quarter to modestly bearish now. The stock trades well below its 200-day moving average of about $69 and sits only a few dollars above its post-earnings low of $48.25, far from the $92.55 high. That positioning cuts both ways: expectations embedded in the share price look depressed, but the chart shows no sign yet that buyers have regained control.

The central question is whether ACM's record order growth is flowing through to revenue on schedule. If the company can show that supply constraints are not derailing shipments, that SPM is beginning to lift cleaning sales and that margins are holding, the improving narrative from last quarter remains intact. If not, the market's harsh verdict may prove to have been early rather than wrong.